EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment (Q35005741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Richard G Gorlick

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Pancras C.W. Hogendoorn

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Paul Meyers

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Matthew R Sydes

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

J S Whelan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S S Bielack

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

N Marina

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Smeland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G Jovic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J M Hook

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M Krailo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Anninga

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

T Butterfass-Bahloul

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

T Böhling

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G Calaminus

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Deffenbaugh

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Dhooge

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A M Flanagan

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

H Gelderblom

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Goorin

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G Gosheger

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R J Grimer

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

K S Hall

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

K Helmke

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G Jundt

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

L Kager

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

T Kuehne

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C C Lau

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G D Letson

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

J Meyer

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Morris

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

H Mottl

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

H Nadel

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R Nagarajan

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R L Randall

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

P Schomberg

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R Schwarz

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

L A Teot

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M Bernstein

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

EURAMOS collaborators

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M Eriksson

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

24 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

407-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R

23 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Incidence and survival of malignant bone sarcomas in England 1979-2007.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

International collaboration is feasible in trials for rare conditions: the EURAMOS experience

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

The role of interferons in the treatment of osteosarcoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionnaire

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Planning the size and duration of a clinical trial studying the time to some critical event

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4304379

The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module.

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU526

Osteosarcoma: time to move on?

21 January 2018

1 reference

12 December 2020

Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarter

1 reference

12 December 2020

Synovial sarcoma. Uniform response of metastases to high dose ifosfamide

1 reference

12 December 2020

SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDU526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

25421877

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25421877%20AND%20SRC:MED&resulttype=core&format=json